These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 21084450)
1. GH-dependent STAT5 signaling plays an important role in hepatic lipid metabolism. Barclay JL; Nelson CN; Ishikawa M; Murray LA; Kerr LM; McPhee TR; Powell EE; Waters MJ Endocrinology; 2011 Jan; 152(1):181-92. PubMed ID: 21084450 [TBL] [Abstract][Full Text] [Related]
2. Growth-hormone-induced signal transducer and activator of transcription 5 signaling causes gigantism, inflammation, and premature death but protects mice from aggressive liver cancer. Friedbichler K; Themanns M; Mueller KM; Schlederer M; Kornfeld JW; Terracciano LM; Kozlov AV; Haindl S; Kenner L; Kolbe T; Mueller M; Snibson KJ; Heim MH; Moriggl R Hepatology; 2012 Mar; 55(3):941-52. PubMed ID: 22031092 [TBL] [Abstract][Full Text] [Related]
3. Growth hormone stimulates transcription of the fibroblast growth factor 21 gene in the liver through the signal transducer and activator of transcription 5. Yu J; Zhao L; Wang A; Eleswarapu S; Ge X; Chen D; Jiang H Endocrinology; 2012 Feb; 153(2):750-8. PubMed ID: 22166977 [TBL] [Abstract][Full Text] [Related]
4. Liver-specific deletion of the signal transducer and activator of transcription 5 gene aggravates fatty liver in response to a high-fat diet in mice. Baik M; Nam YS; Piao MY; Kang HJ; Park SJ; Lee JH J Nutr Biochem; 2016 Mar; 29():56-63. PubMed ID: 26895665 [TBL] [Abstract][Full Text] [Related]
5. Muscle-specific deletion of signal transducer and activator of transcription 5 augments lipid accumulation in skeletal muscle and liver of mice in response to high-fat diet. Baik M; Lee MS; Kang HJ; Park SJ; Piao MY; Nguyen TH; Hennighausen L Eur J Nutr; 2017 Mar; 56(2):569-579. PubMed ID: 26582580 [TBL] [Abstract][Full Text] [Related]
6. Growth hormone STAT5-mediated signaling and its modulation in mice liver during the growth period. Martinez CS; Piazza VG; Ratner LD; Matos MN; González L; Rulli SB; Miquet JG; Sotelo AI Growth Horm IGF Res; 2013; 23(1-2):19-28. PubMed ID: 23245546 [TBL] [Abstract][Full Text] [Related]
7. Loss of signal transducer and activator of transcription 5 leads to hepatosteatosis and impaired liver regeneration. Cui Y; Hosui A; Sun R; Shen K; Gavrilova O; Chen W; Cam MC; Gao B; Robinson GW; Hennighausen L Hepatology; 2007 Aug; 46(2):504-13. PubMed ID: 17640041 [TBL] [Abstract][Full Text] [Related]
8. Constitutively active signal transducer and activator of transcription 5 can replace the requirement for growth hormone in adipogenesis of 3T3-F442A preadipocytes. Shang CA; Waters MJ Mol Endocrinol; 2003 Dec; 17(12):2494-508. PubMed ID: 12970402 [TBL] [Abstract][Full Text] [Related]
12. Hepatic PPARγ Is Not Essential for the Rapid Development of Steatosis After Loss of Hepatic GH Signaling, in Adult Male Mice. Kineman RD; Majumdar N; Subbaiah PV; Cordoba-Chacon J Endocrinology; 2016 May; 157(5):1728-35. PubMed ID: 26950202 [TBL] [Abstract][Full Text] [Related]
13. The activation and differential signalling of the growth hormone receptor induced by pGH or anti-idiotypic monoclonal antibodies in primary rat hepatocytes. Li W; Lan H; Liu H; Fu Z; Yang Y; Han W; Guo F; Liu Y; Zhang H; Liu J; Zheng X Mol Cell Endocrinol; 2013 Aug; 376(1-2):51-9. PubMed ID: 23769824 [TBL] [Abstract][Full Text] [Related]
14. Increased sensitivity to GH in liver of Ames dwarf (Prop1df/Prop1df) mice related to diminished CIS abundance. Miquet JG; Sotelo AI; Dominici FP; Bonkowski MS; Bartke A; Turyn D J Endocrinol; 2005 Dec; 187(3):387-97. PubMed ID: 16423818 [TBL] [Abstract][Full Text] [Related]
15. Ames dwarf (Prop1(df)/Prop1(df)) mice display increased sensitivity of the major GH-signaling pathways in liver and skeletal muscle. Miquet JG; Muñoz MC; Giani JF; González L; Dominici FP; Bartke A; Turyn D; Sotelo AI Growth Horm IGF Res; 2010 Apr; 20(2):118-26. PubMed ID: 20022531 [TBL] [Abstract][Full Text] [Related]
16. Binding of STAT5a and STAT5b to a single element resembling a gamma-interferon-activated sequence mediates the growth hormone induction of the mouse acid-labile subunit promoter in liver cells. Ooi GT; Hurst KR; Poy MN; Rechler MM; Boisclair YR Mol Endocrinol; 1998 May; 12(5):675-87. PubMed ID: 9605930 [TBL] [Abstract][Full Text] [Related]
17. Growth Hormone Control of Hepatic Lipid Metabolism. Liu Z; Cordoba-Chacon J; Kineman RD; Cronstein BN; Muzumdar R; Gong Z; Werner H; Yakar S Diabetes; 2016 Dec; 65(12):3598-3609. PubMed ID: 27679560 [TBL] [Abstract][Full Text] [Related]
18. SIRT1 regulates adaptive response of the growth hormone--insulin-like growth factor-I axis under fasting conditions in liver. Yamamoto M; Iguchi G; Fukuoka H; Suda K; Bando H; Takahashi M; Nishizawa H; Seino S; Takahashi Y Proc Natl Acad Sci U S A; 2013 Sep; 110(37):14948-53. PubMed ID: 23980167 [TBL] [Abstract][Full Text] [Related]
19. In vivo imaging of hepatic growth hormone signaling. Frank SJ; Wang X; He K; Yang N; Fang P; Rosenfeld RG; Hwa V; Chaudhuri TR; Deng L; Zinn KR Mol Endocrinol; 2006 Nov; 20(11):2819-30. PubMed ID: 16803867 [TBL] [Abstract][Full Text] [Related]
20. Growth hormone-dependent pathogenesis of human hepatic steatosis in a novel mouse model bearing a human hepatocyte-repopulated liver. Tateno C; Kataoka M; Utoh R; Tachibana A; Itamoto T; Asahara T; Miya F; Tsunoda T; Yoshizato K Endocrinology; 2011 Apr; 152(4):1479-91. PubMed ID: 21303949 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]